Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)

Back to Funding Opportunities

Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed) - PAR-24-121

Funder

National Institutes of Health

LOI Deadline

April 25, 2025 ;

August 25, 2025 ;

April 25, 2026 ;

August 25, 2026

LOI Required

Recommended, but not required

Application Deadline

May 25, 2025 ;

September 25, 2025 ;

May 25, 2026 ;

September 25, 2026

Maximum Project Duration

5 years

Research Focus Areas

Training (e.g. community providers, staff, faculty, peers)

Alzheimer’s Disease, Dementia, and Neurocognitive Disorders

Description

This Notice of Funding Opportunity (NOFO) seeks to enable the development of a diverse, translational research workforce capable of participating and/or leading cross-disciplinary team science programs focused on advancing translational research for Alzheimer's disease (AD) and AD-related dementias (ADRD). This NOFO will support institutional training programs for predoctoral and postdoctoral level researchers from various educational backgrounds (i.e., basic biology, translational and clinical research, data science, and behavioral research). The program invites eligible institutions to develop interdisciplinary training programs that will provide trainees with the knowledge and skills necessary to conduct rigorous and cutting-edge basic, translational, behavioral, population-based, and clinical research for AD/ADRD.